Activation of the virus-induced IKK/NF-κB signalling axis is critical for the replication of human cytomegalovirus in quiescent cells

Cellular Microbiology

Volumn 9, Issue 8, 2007, Pages 2040-2054

  Caposio, Patrizia ^a   Luganini, Anna ^a   Hahn, Gabriele ^b   Landolfo, Santo ^a   Gribaudo, Giorgio ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUTANT PROTEIN;

ADENOVIRUS; ARTICLE; CELL CULTURE; CELL TYPE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME DEGRADATION; FIBROBLAST; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VIRUS GENE; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN;

CELL LINE; CYTOMEGALOVIRUS; ENDOTHELIAL CELLS; ENHANCER ELEMENTS (GENETICS); ENZYME ACTIVATION; FIBROBLASTS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; I-KAPPA B KINASE; IMMEDIATE-EARLY PROTEINS; MUTATION; NF-KAPPA B; PROMOTER REGIONS (GENETICS); SIGNAL TRANSDUCTION; VIRUS REPLICATION;

HUMAN HERPESVIRUS 5;

EID: 34447639967     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2007.00936.x     Document Type: Article

References (37)

1. Becker, T.C., Noel, R.J., Coats, W.S., Gòmex-Foix, A.M.A., Lam, T., Gerard, R.D., and Newgard, C.B. (1994) Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol 43: 161-189.
2. Benedict, C.A., Angulo, A., Ha, S., Huang, H., Messerle, M., Ware, C.F., and Ghazal, P. (2004) Neutrality of the canonical NF-κB pathway for human and murine cytomegalovirus transcription and replication in vitro. J Virol 78: 741-750.
3. Bissinger, A.L., Sinzger, C., Kaiserling, E., and Jahn, G. (2002) Human cytomegalovirus as a direct pathogen: Correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease. J Med Virol 67: 200-206.
4. Bonizzi, G., and Karin, M. (2004) The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25: 280-288.
5. Browne, E.P., and Shenk, T. (2003) Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells. Proc Natl Acad Sci USA 100: 11439-11444.
6. Caposio, P., Dreano, M., Garotta, G., Gribaudo, G., and Landolfo, S. (2004) Human cytomegalovirus stimulates IKK2 activity and requires the enzyme for productive replication. J Virol 78: 3190-3195.
7. Caposio, P., Musso, T., Luganini, A., Inoue, H., Gariglio, M., Landolfo, S., and Gribaudo, G. (2007) Targeting the NF-κB pathway through pharmacological inhibition of IKK2 prevents human cytomegalovirus replication and virus-induced inflammatory response in infected endothelial cells. Antiviral Res 73: 175-184.
8. DeMeritt, I.B., Milford, L., and Yurochko, A.D. (2004) Activation of the NF-κB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter. J Virol 78: 4498-4507.
9. DeMeritt, I.B., Podduturi, J.P., Tilley, A.M., Nogalski, M.T., and Yurochko, A.D. (2006) Prolonged activation of NF-κB by human cytomegalovirus promotes efficient viral replication and late gene expression. Virology 346: 15-31.
10. Eickhoff, J.E., and Cotten, M. (2005) NF-κB activation can mediate inhibition of human cytomegalovirus replication. J Gen Virol 86: 285-295.
11. Evers, D.L., Wang, X., and Huang, E.S. (2004) Cellular stress and signal transduction responses to human cytomegalovirus infection. Microbes Infect 6: 1084-1093.
12. Fortunato, E.A., McElroy, A.K., Sanchez, V., and Spector, D.H. (2000) Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus. Trends Microbiol 8: 111-119.
13. Gerna, G., Baldanti, F., Zavattoni, M., Sarasini, A., Percivalle, E., and Revello, M.G. (1992) Monitoring of ganciclovir sensitivity of multiple human cytomegalovirus strains coinfecting blood of an AIDS patient by an immediate-early antigen plaque assay. Antivir Res 19: 333-345.
14. Gribaudo, G., Riera, L., Rudge, T.L., Caposio, P., Johnson, L.F., and Landolfo, S. (2002) Human cytomegalovirus infection induces cellular thymidylate synthase gene expression in quiescent fibroblasts. J Gen Virol 83: 2983-2993.
15. Gustems, M., Borst, E., Benedict, C.A., Perez, C., Messerle, M., Ghazal, P., and Angulo, A. (2006) Regulation of the transcription and replication cycle of human cytomegalovirus is insensitive to genetic elimination of the cognate NF-κB binding sites in the enhancer. J Virol 80: 9899-9904.
16. Hahn, G., Khan, H., Baldanti, F., Koszinowski, U.H., Revello, M.G., and Gerna, G. (2002) The human cytomegalovirus ribonucleotide reductase homolog UL45 is dispensable for growth in endothelial cells, as determined by BAC-cloned clinical isolate of human cytomegalovirus with preserved wild-type characteristics. J Virol 76: 9551-9555.
17. Hiscott, J., Kwon, H., and Génin, P. (2001) Hostile takeovers: viral appropriation of the NF-κB pathway. J Clin Invest 107: 143-151.
18. Isomura, H., Tsurumi, T., and Stinski, M.F. (2004) Role of the proximal enhancer of the major immediate-early promoter in human cytomegalovirus replication. J Virol 78: 12788-12799.
19. Jarvis, M.A., Borton, J.A., Keech, A.M., Wong, J., Britt, W.J., Magun. B.E., and Nelson, J.A. (2006) Human cytomegalovirus attenuates interleukin-1β and tumor necrosis factor alpha proinflammatory signaling by inhibition of NF-κB activation. J Virol 80: 5588-5598.
20. Kowalik, T.F., Wing, B., Haskill, J.S., Azizkhan, A., Baldwin, A.S., and Huang, E.S. (1993) Multiple mechanisms are implicated in the regulation of NF-κB activity during human cytomegalovirus infection. Proc Natl Acad Sci USA 90: 1107-1111.
21. Landolfo, S., Gariglio, M., Gribaudo, G., and Lembo, D. (2003) The human cytomegalovirus. Pharmacol Therapeut 98: 269-297.
22. Meier, J.L., and Stinski, M.F. (2006) Major immediate-early enhancer and its gene products. In Cytomegaloviruses. Molecular Biology and Immunology. Reddehase, M. (ed.). Norfolk: Caister Academic Press, pp. 151-166.
23. Mocarski, E.S., and Courcelle, C.T. (2001) Cytomegalovirus and their replication. In Fields Virology. Knipe, D.M., and Howley, P.M. (eds). New York: Lippincot-Raven, pp. 2629-2673.
24. Montag, C., Wagner, J., Gruska, I., and Hagemeier, C. (2006) Human cytomegalovirus blocks TNF-α and IL-1β-mediated NF-κB signaling. J Virol 80: 11686-11698.
25. Otzinger, W., Hofer-Warbinek, R., Schmid, J.A., Koshelnick, Y., Binder, B.R., and de Martin, R. (2001) Adenovirus-mediated expression of a mutant IκB kinase 2 inhibits the response of endothelial cells to inflammatory stimuli. Blood 97: 1611-1617.
26. Pass, R.F. (2001) Cytomegalovirus. In Fields Virology. Knipe, D.M., and Howley, P.M. (eds). New York: Lippincot-Raven, pp. 2675-2705.
27. Prosch, S., Wuttke, R.N., Kruger, D.H., and Volk, H.D. (2002) NF-κB - a potential therapeutic target for inhibition of human cytomegalovirus (re)activation? Biol Chem 383: 1601-1609.
28. Prosch, S., Priemer, C., Hoflich, C., Liebenthal, C., Babel, N., Kruger, D.H., and Volk, H.D. (2003) Proteasome inhibitors: A novel tool to suppress human cytomegalovirus replication and virus-induced immune modulation. Antivir Ther 8: 555-567.
29. Revello, M.G., Baldanti, F., Percivalle, E., Sarasini, A., De-Giuli, L., Genini, E., et al. (2001) In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells. J Gen Virol 82: 1429-1438.
30. Sambucetti, L.C., Cherrington, J.M., Wilkinson, G.W.G., and Mocarski, E.S. (1989) NF-κB activation of the human cytomegalovirus enhancer is mediated by viral transactivator and T-cell stimulation. EMBO J 8: 4251-4258.
31. Santoro, M.G., Rossi, A., and Amici, C. (2003) NF-κB and virus infection: Who controls whom. EMBO J 22: 2552-2560.
32. Sinzger, C., Grefte, A., Plachter, B., Gouw, A.S.H., The, T.H., and Jahn, G. (1995) Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are the major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol 76: 741-750.
33. Tanaka, N., Kimura, H., Iida, K., Saito, K., Tsuge, I., Yoshimi, A., et al. (2000) Quantitative analysis of cytomegalovirus load using a real-time PCR assay. J Med Virol 60: 455-462.
34. Tato, C.M., and Hunter, C.A. (2002) Host-pathogen interactions: subversion and utilization of the NF-κB pathway during infection. Infect Immun 70: 3311-3317.
35. Warming, S., Costantino, N., Court, D.L., Jenkins, N.A., and Copeland, N.G. (2005) Simple and highly efficient BAC recombineering using galK selection. Nucl Acids Res 33: E36.
36. Yurochko, A.D., Kowalik, T.F., Huong, S.M., and Huang, E.S. (1995) Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J Virol 69: 5391-5400.
37. Yurochko, A.D., Hwang, E.S., Rasmussen, L., Keay, S., Pereira, L., and Huang, E.S. (1997) The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection. J Virol 71: 5051-5059.